Testing a new asthma control step-up approach
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial studies how stepping up asthma treatment affects asthma control in people with mild to moderate asthma. You may be asked to use study inhalers correctly and track symptoms and lung tests to see if control improves.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be able to sign consent and follow study visits and instructions
- Be older than 12 years
- Have mild or moderate asthma and meet lung test results (FEV1 at least 60%)
- Show reversibility on a breathing test (at least 12% or 200 ml improvement)
- Not smoke
- If you can get pregnant, you must not be pregnant and use reliable birth control
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether starting treatment with a combination anti-inflammatory and reliever inhaler can help people with new, mild asthma control their symptoms better. It compares different treatment strategies to find the best approach for early asthma care.
This trial tests whether stepping up to either a higher dose of inhaled steroid/long-acting bronchodilator or a special fine-particle triple therapy (which includes an extra medication) can improve small-airway health in people whose asthma is still not well controlled on a medium-dose combination.
This Phase 2 study checks how glycopyrronium bromide works in children with asthma, including its safety and how well inhaler dosing is tolerated. It also uses breathing tests and inhaler technique checks to confirm your child meets key asthma and lung function requirements.
This study tests an investigational drug to see if it can improve asthma control in people whose asthma is not well managed with current treatments. It may help reduce symptoms and improve lung function.
This study tests if a treatment plan called GDMT can help people whose asthma is not well controlled even with high-dose inhaled steroids and long-acting bronchodilators. It is for adults who have had at least one asthma flare-up in the past year.
This study tests a new injected medicine (RC1416) for people with moderate-to-severe asthma that is not well controlled with daily inhalers. It may help reduce asthma attacks and improve breathing.
Hear when a new Bronchial Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.